Prof. Gianni Bisogno
Curriculum Vitae
Scopus ID: 7003672935
Gianni Bisogno is Full Professor of Pediatrics and, since October 2026, Director of the Department of Women’s and Children’s Health at the University of Padua. He is a consultant pediatric oncologist at Padua University Hospital and leads the Laboratory for Advanced Diagnostics and Target Discovery in Rare Pediatric Solid Tumors at the Institute of Pediatric Research. He coordinated the PhD Program in Developmental Medicine and Health Planning Sciences from 2000 to 2026.
His clinical and research activities focus on focus on pediatric solid tumors, particularly pediatric soft tissue sarcomas and very rare tumors. As Coordinator of the Italian Soft Tissue Sarcoma Committee, he has promoted national clinical trials and developed a multidisciplinary network supporting pediatric oncology centers across Italy through central diagnostic review, molecular characterization and advice on complex cases.
He is a founding member of the European paediatric Soft tissue sarcoma Study Group (EpSSG), which he chaired from 2014 to 2019. As Principal Investigator of RMS2005 trial, he helped establish maintenance chemotherapy as a standard treatment for rhabdomyosarcoma; the findings were awarded by the American Society of Clinical Oncology and presented at the 2018 ASCO Plenary Session. Since 2018, he has co-chaired the International Soft Tissue Sarcoma Consortium (INSTRuCT), promoting transatlantic collaboration through joint data analyses, consensus recommendations and guidelines.
Experience gained with such rare tumors as pediatric sarcomas was pivotal in establishing a new collaborative scheme in 2000 called the TREP (Tumori rari in età pediatrica) project. This has been the most successful initiative in favor of children with very rare tumors (nasopharyngeal carcinoma, pediatric melanoma, pleuropulmonary blastoma, and others) that have tended to be rather neglected by the pediatric oncology community. This model contributed to the foundation of the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) in Padua in 2008.
He represents Padua University Hospital within ERN PaedCan and coordinates PARTNER, the EU-funded project that developed a European registry for children and adolescents with very rare tumors.
His translational research focuses on diagnostic tools, prognostic biomarkers and therapeutic targets, with contributions to identifying VGLL2-related fusions in spindle cell rhabdomyosarcoma and other different prognostic biomarkers (miR-26a, IGFBP2 and others).
He has received 58 competitive grants, including six EU-funded projects: EPOC, ENCCA, ExPO-r-Net, UNICA4EU and PARTNER4VRT as a partner, and PARTNER as coordinator.
He has authored more than 400 peer-reviewed international publications and 16 book chapters. His Scopus h-index is 62 (October 2026).
Related Research Area
Pediatric Hematology, Oncology and Hematopoietic cell&gene therapy
Related Laboratories
Advanced Diagnostics and Target Discovery in Rare Pediatric Solid Tumors